These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 23089374)

  • 1. The rapid recovery of 5-HT cell firing induced by the antidepressant vortioxetine involves 5-HT(3) receptor antagonism.
    Bétry C; Pehrson AL; Etiévant A; Ebert B; Sánchez C; Haddjeri N
    Int J Neuropsychopharmacol; 2013 Jun; 16(5):1115-27. PubMed ID: 23089374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 2, pharmacological interactions in rodents suggest a role of serotonin-3 receptor antagonism.
    Leiser SC; Iglesias-Bregna D; Westrich L; Pehrson AL; Sanchez C
    J Psychopharmacol; 2015 Oct; 29(10):1092-105. PubMed ID: 26174134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of 5-HT3 receptors in the action of vortioxetine in rat brain: Focus on glutamatergic and GABAergic neurotransmission.
    Riga MS; Sánchez C; Celada P; Artigas F
    Neuropharmacology; 2016 Sep; 108():73-81. PubMed ID: 27106166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the multimodal acting antidepressant vortioxetine on rat hippocampal plasticity and recognition memory.
    Bétry C; Etiévant A; Pehrson A; Sánchez C; Haddjeri N
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Apr; 58():38-46. PubMed ID: 25524057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lu AA21004, a novel multimodal antidepressant, produces regionally selective increases of multiple neurotransmitters--a rat microdialysis and electrophysiology study.
    Pehrson AL; Cremers T; Bétry C; van der Hart MG; Jørgensen L; Madsen M; Haddjeri N; Ebert B; Sanchez C
    Eur Neuropsychopharmacol; 2013 Feb; 23(2):133-45. PubMed ID: 22612991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vortioxetine dose-dependently reverses 5-HT depletion-induced deficits in spatial working and object recognition memory: a potential role for 5-HT1A receptor agonism and 5-HT3 receptor antagonism.
    du Jardin KG; Jensen JB; Sanchez C; Pehrson AL
    Eur Neuropsychopharmacol; 2014 Jan; 24(1):160-71. PubMed ID: 23916504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice.
    Guilloux JP; Mendez-David I; Pehrson A; Guiard BP; Repérant C; Orvoën S; Gardier AM; Hen R; Ebert B; Miller S; Sanchez C; David DJ
    Neuropharmacology; 2013 Oct; 73():147-59. PubMed ID: 23721744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder.
    Bang-Andersen B; Ruhland T; Jørgensen M; Smith G; Frederiksen K; Jensen KG; Zhong H; Nielsen SM; Hogg S; Mørk A; Stensbøl TB
    J Med Chem; 2011 May; 54(9):3206-21. PubMed ID: 21486038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The multimodal antidepressant vortioxetine may facilitate pyramidal cell firing by inhibition of 5-HT
    Dale E; Grunnet M; Pehrson AL; Frederiksen K; Larsen PH; Nielsen J; Stensbøl TB; Ebert B; Yin H; Lu D; Liu H; Jensen TN; Yang CR; Sanchez C
    Brain Res; 2018 Jun; 1689():1-11. PubMed ID: 29274875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonergic receptor mechanisms underlying antidepressant-like action in the progesterone withdrawal model of hormonally induced depression in rats.
    Li Y; Raaby KF; Sánchez C; Gulinello M
    Behav Brain Res; 2013 Nov; 256():520-8. PubMed ID: 24016840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional distribution of serotonergic receptors: a systems neuroscience perspective on the downstream effects of the multimodal-acting antidepressant vortioxetine on excitatory and inhibitory neurotransmission.
    Pehrson AL; Jeyarajah T; Sanchez C
    CNS Spectr; 2016 Apr; 21(2):162-83. PubMed ID: 26250622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single dose of vortioxetine, but not ketamine or fluoxetine, increases plasticity-related gene expression in the rat frontal cortex.
    du Jardin KG; Müller HK; Sanchez C; Wegener G; Elfving B
    Eur J Pharmacol; 2016 Sep; 786():29-35. PubMed ID: 27235984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of time- and sex-dependent effects of vortioxetine on rat sexual behavior: Possible roles of direct receptor modulation.
    Li Y; Pehrson AL; Oosting RS; Gulinello M; Olivier B; Sanchez C
    Neuropharmacology; 2017 Jul; 121():89-99. PubMed ID: 28414050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin Transporter-Independent Actions of the Antidepressant Vortioxetine As Revealed Using the SERT Met172 Mouse.
    Nackenoff AG; Simmler LD; Baganz NL; Pehrson AL; Sánchez C; Blakely RD
    ACS Chem Neurosci; 2017 May; 8(5):1092-1100. PubMed ID: 28272863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT(1A) agonist potential of pindolol: electrophysiologic studies in the dorsal raphe nucleus and hippocampus.
    Sprouse J; Braselton J; Reynolds L
    Biol Psychiatry; 2000 Jun; 47(12):1050-5. PubMed ID: 10862804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data.
    Sanchez C; Asin KE; Artigas F
    Pharmacol Ther; 2015 Jan; 145():43-57. PubMed ID: 25016186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the rat.
    Lucas G; Du J; Romeas T; Mnie-Filali O; Haddjeri N; Piñeyro G; Debonnel G
    PLoS One; 2010 Feb; 5(2):e9253. PubMed ID: 20169084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the potential antidepressant OPC-14523 [1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolinone monomethanesulfonate] a combined sigma and 5-HT1A ligand: modulation of neuronal activity in the dorsal raphe nucleus.
    Bermack JE; Haddjeri N; Debonnel G
    J Pharmacol Exp Ther; 2004 Aug; 310(2):578-83. PubMed ID: 15044555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HTT and 5-HT(1A) receptor occupancy of the novel substance vortioxetine (Lu AA21004). A PET study in control subjects.
    Stenkrona P; Halldin C; Lundberg J
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1190-8. PubMed ID: 23428337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo electrophysiological study of the targeting of 5-HT
    Schweimer JV; Brouard JT; Li Y; Sánchez C; Sharp T
    Eur J Neurosci; 2022 Mar; 55(6):1409-1423. PubMed ID: 35146812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.